Dr Diane Jorkasky joins Aileron
This article was originally published in Scrip
Executive Summary
Aileron Therapeutics (US) has appointed Dr Diane Jorkasky senior vice-president, head of development and chief medical officer. Dr Jorkasky joins after almost 10 years at Pfizer, where she most recently served as vice-president of development, head of worldwide clinical research operations and leader of the operational excellence board for development. Aileron was first funded in 2005 by Apple Tree Partners to develop and advance a new therapeutic modality and class of drugs called Stapled Peptides, which are based on discoveries